Last reviewed · How we verify
Metastatic Breast Carcinoma
Approved treatments
- Fareston · Kyowa Kirin
Fareston works by binding to estrogen receptors in the body, which can help reduce the growth of breast cancer cells. - Carac · Spectrum Pharms
- Xeloda · Cheplapharm
Xeloda works by inhibiting the enzyme thymidylate synthase, which is necessary for DNA synthesis in cancer cells. - Gemcitabin · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Ixempra Kit · R-Pharm Us Llc
Ixempra Kit works by disrupting cell division, preventing cancer cells from growing and multiplying. - Estrace · Pfizer
Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Gemzar · Accord Hlthcare
Gemcitabine kills cells during DNA synthesis and blocks G1/S-phase progression. - Taxol · Pfizer
Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division. - adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Taxotere · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Vinblastin · The Lymphoma Academic Research Organisation
- Estring · Pfizer Inc.
Prevents pregnancy primarily by suppressing ovulation. - Halaven · Eisai
Halaven works by binding to tubulin beta, disrupting microtubule dynamics and leading to cell death. - Docetaxol · Fudan University
- Gemzar · Accord Hlthcare
Gemzar works by mimicking a building block of DNA, tricking cancer cells into incorporating it into their DNA and then stopping the replication process. - Carac · Extrovis
- Taxol · Pfizer
- Liposomal Doxorubicin · Pfizer
- Taxotere · Sanofi
Taxotere works by binding to microtubules, preventing them from disassembling and thereby blocking cell division. - Taxol · Pfizer
- Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Hydroxydaunomycin · Weill Medical College of Cornell University
- Xeloda · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Abraxane · The First Affiliated Hospital with Nanjing Medical University
- Adriamycin · Johann Wolfgang Goethe University Hospital
- Taxol · M.D. Anderson Cancer Center
Clinical guidelines
- FDA label — 1L
Gemcitabine Injection in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. - FDA label — 2L
Estring (estradiol) is indicated for the palliative treatment of advanced or metastatic breast carcinoma in postmenopausal women with estrogen receptor-positive tumors. - FDA label — 1L
Gemcitabine Injection in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic Breast Carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic Breast Carcinoma treatment landscape brief
- Metastatic Breast Carcinoma treatment updates RSS
Frequently asked questions about Metastatic Breast Carcinoma
What drugs treat Metastatic Breast Carcinoma?
Tracked treatments include Fareston, Carac, Xeloda, Gemcitabin, Ixempra Kit, Estrace, Gemzar, Taxol.
What is the treatment for Metastatic Breast Carcinoma?
Standard treatment for Metastatic Breast Carcinoma includes Fareston, Carac, Xeloda, Gemcitabin, Ixempra Kit. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Metastatic Breast Carcinoma?
FDA label publishes guidelines for Metastatic Breast Carcinoma. 3 guideline references tracked.
Related
- Treatment landscape: Metastatic Breast Carcinoma patent cliff · Metastatic Breast Carcinoma CI report
- Treatment: Fareston · Kyowa Kirin
- Treatment: Carac · Spectrum Pharms
- Treatment: Xeloda · Cheplapharm
- Treatment: Gemcitabin · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Treatment: Ixempra Kit · R-Pharm Us Llc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing